Blog
Why Most Peptides Fail When Swallowed, and How Oral Semaglutide Works Around It
Insulin was discovered in 1921, and a swallowable version has been sought ever since. The difficulty is not a lack of effort. A swallowed peptide faces a gauntlet that is almost custom-built to destroy it.
Key takeaways
- Acid, pepsin and intestinal proteases degrade peptides.
- Peptides are too large and polar to cross the intestinal lining easily.
- Typical oral bioavailability for peptides is well under 2 percent.
- Absorption enhancers such as SNAC and chemical stabilization can lift it to a workable level for potent compounds.
The gauntlet
- Stomach. Acid at pH 1 to 3 and pepsin cleave peptide bonds and can unfold peptides.
- Small intestine. Trypsin, chymotrypsin, elastase and brush-border peptidases rapidly break down short chains.
- Mucus layer. Slows access to the lining.
- Epithelium. Tight junctions block the gaps between cells, and the cell membranes are lipid barriers that hydrophilic, hydrogen-bond-rich peptides cannot cross easily. Peptides above a few hundred daltons mostly use the paracellular route poorly.
- Liver first pass. Anything absorbed passes through the liver before reaching the general circulation.
Numbers
Oral bioavailability of unmodified peptides is typically below 1 to 2 percent. Even optimized oral semaglutide has an absolute bioavailability reported at around 1 percent or less, which is why the oral tablet needs a much larger dose than the injectable.
The SNAC approach
Oral semaglutide combines the peptide with salcaprozate sodium (SNAC), a small absorption enhancer, in a tablet designed to dissolve in the stomach. Studies describe several effects of SNAC: it raises the local pH around the tablet, which reduces pepsin activity, it helps keep the peptide in monomer form, and it promotes absorption across the stomach lining by a transcellular route. Semaglutide itself has also been engineered for stability, with amino acid substitutions that resist DPP-4 and a fatty chain for albumin binding (see half-life engineering). The success relies on both: a potent, stable peptide and a local enhancer.
Other strategies in research
- Permeation enhancers that transiently open tight junctions or fluidize membranes.
- Enzyme inhibitors co-delivered to protect the peptide.
- Cyclization and N-methylation to improve stability and permeability (see cyclic peptides). Cyclosporine is a naturally cyclic, N-methylated peptide that is orally absorbed.
- Enteric coatings and nanoparticles that protect passage through the stomach.
- Alternative routes such as nasal, buccal, pulmonary and transdermal delivery.
Why route matters for interpretation
A result obtained by injection in an animal cannot be assumed to hold by mouth. Our posts on nasal versus injectable delivery and mucosal versus systemic pathways explain how the route changes what reaches the target.
The bottom line
The gut is built to take proteins apart. Oral peptide drugs exist, but they are feats of engineering, and the exception does not mean peptides in general survive digestion.
Related reading
- Nasal vs. Injectable BPC-157: What Delivery-Method Research Shows
- Mucosal vs. Systemic Pathways: A Closer Look at Nasal Peptide Research Models
- How Researchers Make Peptides Last Longer: D-Amino Acids, Acylation and More
- Browse the full Research Library
Explore Lucid Aminos
- Shop all research compounds
- Read the lab reports (COA)
- Monthly Research Panel
- Frequently asked questions
- Partner program
- About Lucid Aminos
- Contact us
For laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any condition. This article is educational and is not medical advice.